Global Nanotechnology in Drug Delivery Market to Reach $122.7 Billion by 2030
The global market for Nanotechnology in Drug Delivery estimated at US$68.5 Billion in the year 2022, is projected to reach a revised size of US$122.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2022-2030. Nanoparticles, one of the segments analyzed in the report, is projected to record 7.8% CAGR and reach US$35.6 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Liposomes segment is readjusted to a revised 7.9% CAGR for the next 8-year period.The U.S. Market is Estimated at $18.5 Billion, While China is Forecast to Grow at 12.5% CAGR
The Nanotechnology in Drug Delivery market in the U.S. is estimated at US$18.5 Billion in the year 2022. China, the world's second largest economy, is forecast to reach a projected market size of US$30.6 Billion by the year 2030 trailing a CAGR of 12.5% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.9% and 6.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 4% CAGR.Select Competitors (Total 36 Featured) -
- AbbVie Inc.
- Aquanova AG
- BlueWillow Biologics
- Camurus AB
- Celgene, Inc.
- Ceramisphere Health Pty Limited
- Cristal Therapeutics
- CYTIMMUNE SCIENCES, Inc.
- EnColl Corporation
- EyePoint Pharmaceuticals
- Lena Nanoceutics Ltd.
- Nanobiotix
- NanoCarrier Co., Ltd.
- NanOlogy LLC
- Nanospectra Biosciences, Inc.
- Parvus Therapeutics Inc.
- Selecta Biosciences
- Starpharma Holdings Limited
- Taiwan Liposome Co.,
- Tarveda Therapeutics
What's New?
- Special coverage on Russia-Ukraine war; global inflation; easing of zero-Covid policy in China and its `bumpy` reopening; supply chain disruptions, global trade tensions; and risk of recession.
- Global competitiveness and key competitor percentage market shares
- Market presence across multiple geographies - Strong/Active/Niche/Trivial
- Online interactive peer-to-peer collaborative bespoke updates
- Access to digital archives and Research Platform
- Complimentary updates for one year
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARYIII. MARKET ANALYSISSOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
- Influencer Market Insights
- World Market Trajectories
- Nanotechnology, A Critical Part of Healthcare Reform
- Recent Market Activity
- Nanomedicine, Revolutionizing the Basics of Medicine
- A Peek Into the Evolving Role of Nanoparticles in Nanomedicine
- Nanocrystals Continue to Gain Momentum as Alternatives to Traditional Nanocarriers
- Nanocarriers Enable Targeted Drug Delivery Systems to Improve Therapeutic Outcomes
- Advanced Liposomes Enable Low Soluble Drugs to Achieve Targeted Delivery
- Multifunctional Dendrimers Present an Ideal Structure for Targeted Drug Delivery
- High Drug Loading Capacity of PAMAM Dendrimers Bodes Well for Targeted Drug Delivery Systems
- Nanotechnology-Based Strategies for siRNA Grows in Popularity
- NEM Devices as Drug Delivery Vehicles
- Nanotechnology - In Pursuit of Co-Delivery of Drugs
- Nanoemulsions Begin to Make a Mark
- Nanotechnology Finds Increasing Role in Fighting Infectious Diseases
- List of Select Nanotechnology-based Antimicrobial Drugs in Clinical Use
- Nanotechnology Opening New Avenues in Antiretroviral Therapy
- Demonstrated Activity of Select Nanotechnology- Delivered Antiretroviral Therapies
- Nanotechnology in Delivery of CNS Therapeutics
- Market Outlook
- Nanotechnology in Drug Delivery - Global Key Competitors Percentage Market Share in 2022 (E)
- Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
- Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
- AbbVie Inc. (USA)
- Aquanova AG (Germany)
- BlueWillow Biologics (USA)
- Camurus AB (Sweden)
- Celgene, Inc. (Canada)
- Ceramisphere Health Pty Limited (Australia)
- Cristal Therapeutics (The Netherlands)
- CYTIMMUNE SCIENCES, INC. (Italy)
- EnColl Corporation (USA)
- EyePoint Pharmaceuticals (USA)
- Lena Nanoceutics Ltd. (UK)
- NanOlogy LLC (USA)
- NanoCarrier Co., Ltd. (Japan)
- Nanobiotix (France)
- Nanospectra Biosciences, Inc (USA)
- Parvus Therapeutics Inc. (USA)
- Selecta Biosciences (USA)
- Starpharma Holdings Limited (Australia)
- Taiwan Liposome Co. (Taiwan)
- Tarveda Therapeutics (USA)
3. MARKET TRENDS & DRIVERS
- Growing Need for Alternative Approaches to Conventional Chemotherapy Creates Opportunities for Nanoparticles
- Stimuli Responsive Polymeric Micelles Promise Enhanced Therapeutic Effect for Hydrophobic Anticancer Drugs
- Inorganic Nanocarriers Facilitate High Payload Capacity and Co-Delivery Platforms for MDR Cancer Therapy
- Solid Lipid Nanoparticles Provide Increased Physical Stability in Targeted Drug Delivery
- Pulmonary Delivery of Nanoparticle-Based Drugs Receives Increased Interest
- Inhalable Liposome Formulations Attract Research Interest in Pulmonary Delivery
- SLNs in Pulmonary Delivery of Drugs
- Market Challenges
- Increasing Environmental and Health Concerns
- Limited Success and Scaling Up Issues Pose a Major Hurdle to Further Advancement
- Higher Concentration of Research in Academia limits Commercialization
- Collaborations Assume Importance
- Nanomedicine Regulation
4. GLOBAL MARKET PERSPECTIVE
- Table 1: World Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 2: World 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2023 & 2030
- Table 3: World Recent Past, Current & Future Analysis for Nanocrystals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 4: World 8-Year Perspective for Nanocrystals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 5: World Recent Past, Current & Future Analysis for Nanoparticles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 6: World 8-Year Perspective for Nanoparticles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 7: World Recent Past, Current & Future Analysis for Liposomes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 8: World 8-Year Perspective for Liposomes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 9: World Recent Past, Current & Future Analysis for Nano Emulsions by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 10: World 8-Year Perspective for Nano Emulsions by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 11: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 12: World 8-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 13: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 14: World 8-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 15: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 16: World 8-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 17: World Recent Past, Current & Future Analysis for Neurology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 18: World 8-Year Perspective for Neurology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 19: World Recent Past, Current & Future Analysis for Anti-Inflammatory by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 20: World 8-Year Perspective for Anti-Inflammatory by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 21: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 22: World 8-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2023 & 2030
- Table 23: World Nanotechnology in Drug Delivery Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
UNITED STATES
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
- Table 24: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 25: USA 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 26: USA Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 27: USA 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
CANADA
- Table 28: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 29: Canada 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 30: Canada Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 31: Canada 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
JAPAN
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
- Table 32: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 33: Japan 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 34: Japan Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 35: Japan 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
CHINA
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
- Table 36: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 37: China 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 38: China Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 39: China 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
EUROPE
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
- Table 40: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 41: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2023 & 2030
- Table 42: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 43: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 44: Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 45: Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
FRANCE
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
- Table 46: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 47: France 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 48: France Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 49: France 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
GERMANY
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
- Table 50: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 51: Germany 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 52: Germany Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 53: Germany 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
ITALY
- Table 54: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 55: Italy 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 56: Italy Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 57: Italy 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
UNITED KINGDOM
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2023 (E)
- Table 58: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 59: UK 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 60: UK Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 61: UK 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
SPAIN
- Table 62: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 63: Spain 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 64: Spain Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 65: Spain 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
RUSSIA
- Table 66: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 67: Russia 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 68: Russia Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 69: Russia 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
REST OF EUROPE
- Table 70: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 71: Rest of Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 72: Rest of Europe Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 73: Rest of Europe 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
ASIA-PACIFIC
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2023 (E)
- Table 74: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
- Table 75: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2023 & 2030
- Table 76: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Technology - Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 77: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Technology - Percentage Breakdown of Value Sales for Nanoparticles, Liposomes, Nanocrystals, Nano Emulsions and Other Technologies for the Years 2023 & 2030
- Table 78: Asia-Pacific Recent Past, Current & Future Analysis for Nanotechnology in Drug Delivery by Application - Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
- Table 79: Asia-Pacific 8-Year Perspective for Nanotechnology in Drug Delivery by Application - Percentage Breakdown of Value Sales for Oncology, Cardiovascular, Neurology, Anti-Inflammatory and Other Applications for the Years 2023 & 2030
AUSTRALIA
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2023 (E)
INDIA
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2023 (E)
LATIN AMERICA
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2023 (E)
MIDDLE EAST
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2023 (E)
AFRICA
- Nanotechnology in Drug Delivery Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2023 (E)
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- AbbVie Inc.
- Aquanova AG
- BlueWillow Biologics
- Camurus AB
- Celgene, Inc.
- Ceramisphere Health Pty Limited
- Cristal Therapeutics
- CYTIMMUNE SCIENCES, Inc.
- EnColl Corporation
- EyePoint Pharmaceuticals
- Lena Nanoceutics Ltd.
- Nanobiotix
- NanoCarrier Co., Ltd.
- NanOlogy LLC
- Nanospectra Biosciences, Inc.
- Parvus Therapeutics Inc.
- Selecta Biosciences
- Starpharma Holdings Limited
- Taiwan Liposome Co.,
- Tarveda Therapeutics
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 272 |
Published | May 2024 |
Forecast Period | 2020 - 2027 |
Estimated Market Value ( USD | $ 55.6 Billion |
Forecasted Market Value ( USD | $ 94.7 Billion |
Compound Annual Growth Rate | 7.9% |
Regions Covered | Global |